McEvoy JP - Search Results

1

High-dose oral ziprasidone versus conventional dosing in schizophrenia patients with residual symptoms: the ZEBRAS study.

Goff DC, McEvoy JP, Citrome L, Mech AW, Bustillo JR, Gil R, Buckley P, Manschreck TC, Achtyes ED, Macklin EA. Goff DC, et al. Among authors: mcevoy jp. J Clin Psychopharmacol. 2013 Aug;33(4):485-90. doi: 10.1097/JCP.0b013e3182977308. J Clin Psychopharmacol. 2013. PMID: 23775057 Clinical Trial.

2

Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol.

Volavka J, Czobor P, Nolan K, Sheitman B, Lindenmayer JP, Citrome L, McEvoy JP, Cooper TB, Lieberman JA. Volavka J, et al. Among authors: mcevoy jp. J Clin Psychopharmacol. 2004 Apr;24(2):225-8. doi: 10.1097/01.jcp.0000117424.05703.29. J Clin Psychopharmacol. 2004. PMID: 15206671 Clinical Trial.

3

Standard and higher dose of olanzapine in patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, fixed-dose study.

Kinon BJ, Volavka J, Stauffer V, Edwards SE, Liu-Seifert H, Chen L, Adams DH, Lindenmayer JP, McEvoy JP, Buckley PF, Lieberman JA, Meltzer HY, Wilson DR, Citrome L. Kinon BJ, et al. Among authors: mcevoy jp. J Clin Psychopharmacol. 2008 Aug;28(4):392-400. doi: 10.1097/JCP.0b013e31817e63a5. J Clin Psychopharmacol. 2008. PMID: 18626265 Clinical Trial.

4

Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.

Volavka J, Czobor P, Sheitman B, Lindenmayer JP, Citrome L, McEvoy JP, Cooper TB, Chakos M, Lieberman JA. Volavka J, et al. Among authors: mcevoy jp. Am J Psychiatry. 2002 Feb;159(2):255-62. doi: 10.1176/appi.ajp.159.2.255. Am J Psychiatry. 2002. PMID: 11823268 Clinical Trial.

5

Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study.

Lindenmayer JP, Czobor P, Volavka J, Lieberman JA, Citrome L, Sheitman B, Chakos M, McEvoy JP. Lindenmayer JP, et al. Among authors: mcevoy jp. J Clin Psychiatry. 2002 Oct;63(10):931-5. doi: 10.4088/jcp.v63n1011. J Clin Psychiatry. 2002. PMID: 12416603 Clinical Trial.

6

Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidol.

Volavka J, Czobor P, Cooper TB, Sheitman B, Lindenmayer JP, Citrome L, McEvoy JP, Lieberman JA. Volavka J, et al. Among authors: mcevoy jp. J Clin Psychiatry. 2004 Jan;65(1):57-61. doi: 10.4088/jcp.v65n0109. J Clin Psychiatry. 2004. PMID: 14744169 Clinical Trial.

7

Effects of atypical antipsychotics on the syndromal profile in treatment-resistant schizophrenia.

Lindenmayer JP, Czobor P, Volavka J, Lieberman JA, Citrome L, Sheitman B, McEvoy JP, Cooper TB, Chakos M. Lindenmayer JP, et al. Among authors: mcevoy jp. J Clin Psychiatry. 2004 Apr;65(4):551-6. doi: 10.4088/jcp.v65n0416. J Clin Psychiatry. 2004. PMID: 15119920 Clinical Trial.

8

Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia.

Javitt DC, Buchanan RW, Keefe RS, Kern R, McMahon RP, Green MF, Lieberman J, Goff DC, Csernansky JG, McEvoy JP, Jarskog F, Seidman LJ, Gold JM, Kimhy D, Nolan KS, Barch DS, Ball MP, Robinson J, Marder SR. Javitt DC, et al. Among authors: mcevoy jp. Schizophr Res. 2012 Apr;136(1-3):25-31. doi: 10.1016/j.schres.2011.11.001. Epub 2011 Dec 12. Schizophr Res. 2012. PMID: 22169248 Clinical Trial.

9

Effectiveness of lurasidone in patients with schizophrenia or schizoaffective disorder switched from other antipsychotics: a randomized, 6-week, open-label study.

McEvoy JP, Citrome L, Hernandez D, Cucchiaro J, Hsu J, Pikalov A, Loebel A. McEvoy JP, et al. J Clin Psychiatry. 2013 Feb;74(2):170-9. doi: 10.4088/JCP.12m07992. J Clin Psychiatry. 2013. PMID: 23473350 Free article. Clinical Trial.

10

Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.

Lindenmayer JP, Czobor P, Volavka J, Citrome L, Sheitman B, McEvoy JP, Cooper TB, Chakos M, Lieberman JA. Lindenmayer JP, et al. Among authors: mcevoy jp. Am J Psychiatry. 2003 Feb;160(2):290-6. doi: 10.1176/appi.ajp.160.2.290. Am J Psychiatry. 2003. PMID: 12562575 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

240 results

Search Page